The price of eFFECTOR Therapeutics Inc (NASDAQ:EFTR) shares last traded on Wall Street fell -1.06% to $0.28.
EFTR stock price is now -83.78% away from the 50-day moving average and -97.15% away from the 200-day moving average. The market capitalization of the company currently stands at $1.32M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target reduced from $20 to $6.20, Stifel Downgraded its rating from Buy to Hold for eFFECTOR Therapeutics Inc (NASDAQ: EFTR). On November 09, 2021, Stifel Upgraded its previous ‘Hold’ rating to ‘Buy’ on the stock keeping its target price maintained at $20, while ‘Credit Suisse’ rates the stock as ‘Outperform’
In other news, SR ONE CAPITAL MANAGEMENT, LLC, 10% Owner sold 609,163 shares of the company’s stock on Nov 27 ’23. The stock was sold for $369,457 at an average price of $0.61. Upon completion of the transaction, the 10% Owner now directly owns 1,821,415 shares in the company, valued at $0.51 million. A total of 13.23% of the company’s stock is owned by insiders.
During the past 12 months, eFFECTOR Therapeutics Inc has had a low of $0.25 and a high of $22.50. As of last week, the company has a debt-to-equity ratio of 23.07, a current ratio of 1.03, and a quick ratio of 1.03. The fifty day moving average price for EFTR is $1.72666 and a two-hundred day moving average price translates $9.82929 for the stock.
The latest earnings results from eFFECTOR Therapeutics Inc (NASDAQ: EFTR) was released for 2024-03-31. The company reported revenue of $8.4 million for the quarter, compared to $9.54 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -11.95 percent.
